These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31168596)

  • 41. Prognostic factors after surgical resection of N1 non-small cell lung cancer.
    Mordant P; Pricopi C; Legras A; Arame A; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
    Eur J Surg Oncol; 2015 May; 41(5):696-701. PubMed ID: 25454825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes.
    Ito M; Yamashita Y; Tsutani Y; Misumi K; Harada H; Miyata Y; Okada M
    Clin Lung Cancer; 2013 Nov; 14(6):651-7. PubMed ID: 24188630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
    Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrapulmonary lymph node (stations 13 and 14) metastasis in peripheral non-small cell lung cancer.
    Bi L; Zhang H; Ge M; Lv Z; Deng Y; Rong T; Liu C
    Medicine (Baltimore); 2021 Jul; 100(27):e26528. PubMed ID: 34232188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
    Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung.
    Sayar A; Turna A; Kiliçgün A; Solak O; Urer N; Gürses A
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):434-8. PubMed ID: 15019674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
    Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC.
    Katsumata S; Aokage K; Ishii G; Nakasone S; Sakai T; Okada S; Miyoshi T; Tane K; Tsuboi M
    J Thorac Oncol; 2019 Aug; 14(8):1408-1418. PubMed ID: 31055075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
    Wu XW; Chen T; Yin S; Deng Y; Zhao B
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
    [No Abstract]   [Full Text] [Related]  

  • 52. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer.
    Ueda K; Kaneda Y; Sakano H; Tanaka T; Hayashi M; Li TS; Hamano K
    Jpn J Thorac Cardiovasc Surg; 2003 Jul; 51(7):297-301. PubMed ID: 12892460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic classifications of lymph node involvement in lung cancer and current International Association for the Study of Lung Cancer descriptive classification in zones.
    Riquet M; Arame A; Foucault C; Le Pimpec Barthes F
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):260-4. PubMed ID: 20573650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Importance of segmental lymph nodes in the pathological staging of non-small cell lung cancer].
    Huang JD; Li XD; Wang RQ; Huang H; Ouyang HC; Yang H
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(22):1714-1718. PubMed ID: 28606280
    [No Abstract]   [Full Text] [Related]  

  • 56. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Size of metastatic and nonmetastatic mediastinal lymph nodes in non-small cell lung cancer.
    Ikeda K; Nomori H; Mori T; Kobayashi H; Iwatani K; Yoshimoto K
    J Thorac Oncol; 2006 Nov; 1(9):949-52. PubMed ID: 17409977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
    Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
    Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
    Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Shaw EG; Marks RS; Frytak S; Lange CM; Li H
    Cancer; 1997 Oct; 80(8):1399-408. PubMed ID: 9338463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.